Literature DB >> 10482544

CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.

S Moir1, R Lapointe, A Malaspina, M Ostrowski, C E Cole, T W Chun, J Adelsberger, M Baseler, P Hwu, A S Fauci.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replicates primarily in lymphoid tissues where it has ready access to activated immune competent cells. We used one of the major pathways of immune activation, namely, CD40-CD40L interactions, to study the infectability of B lymphocytes isolated from peripheral blood mononuclear cells. Highly enriched populations of B lymphocytes generated in the presence of interleukin-4 and oligomeric soluble CD40L upregulated costimulatory and activation markers, as well as HIV-1 receptors CD4 and CXCR4, but not CCR5. By using single-round competent luciferase viruses complemented with either amphotropic or HIV-derived envelopes, we found a direct correlation between upregulation of HIV-1 receptors and the susceptibility of the B lymphocytes to infection with dual-tropic and T-tropic strains of HIV-1; in contrast, cells were resistant to M-tropic strains of HIV-1. HIV-1 envelope-mediated infection was completely abolished with either an anti-CD4 monoclonal antibody or a peptide known to directly block CXCR4 usage and partially blocked with stromal cell-derived factor 1, all of which had no effect on the entry of virus pseudotyped with amphotropic envelope. Full virus replication kinetics confirmed that infection depends on CXCR4 usage. Furthermore, productive cycles of virus replication occurred rapidly yet under most conditions, without the appearance of syncytia. Thus, an activated immunological environment may induce the expression of HIV-1 receptors on B lymphocytes, priming them for infection with selective strains of HIV-1 and allowing them to serve as a potential viral reservoir.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482544      PMCID: PMC112811          DOI: 10.1128/JVI.73.10.7972-7980.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  CD40/CD40L interactions and cytokines regulate HIV replication in B cells in vitro.

Authors:  G Gras; C Legendre; R Krzysiek; D Dormont; P Galanaud; Y Richard
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

2.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

3.  Dendrite cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV.

Authors:  M Pope; D Elmore; D Ho; P Marx
Journal:  AIDS Res Hum Retroviruses       Date:  1997-07-01       Impact factor: 2.205

4.  Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.

Authors:  V Maréchal; F Arenzana-Seisdedos; J M Heard; O Schwartz
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70.

Authors:  K C Wolthers; S A Otto; S M Lens; R A Van Lier; F Miedema; L Meyaard
Journal:  AIDS Res Hum Retroviruses       Date:  1997-08-10       Impact factor: 2.205

6.  HIV-1 LTR activity in human CD40-activated B lymphocytes is dependent on NF-kappaB.

Authors:  R Lapointe; R Lemieux; A Darveau
Journal:  Biochem Biophys Res Commun       Date:  1996-12-24       Impact factor: 3.575

Review 7.  Host factors and the pathogenesis of HIV-induced disease.

Authors:  A S Fauci
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

8.  Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay.

Authors:  S Moir; L Poulin
Journal:  AIDS Res Hum Retroviruses       Date:  1996-06-10       Impact factor: 2.205

9.  A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.

Authors:  B J Doranz; K Grovit-Ferbas; M P Sharron; S H Mao; M B Goetz; E S Daar; R W Doms; W A O'Brien
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  19 in total

1.  Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.

Authors:  Jibreel Jumare; Sara Sunshine; Hayat Ahmed; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Tricia Burdo; Lindsay M Eyzaguirre; Anya Umlauf; Mariana Cherner; Alash'le Abimiku; Man Charurat; Jonathan Z Li; William A Blattner; Walter Royal
Journal:  J Neurovirol       Date:  2017-02-27       Impact factor: 2.643

2.  Maturational characteristics of HIV-specific antibodies in viremic individuals.

Authors:  Eric Meffre; Aaron Louie; Jason Bannock; Leo J Y Kim; Jason Ho; Cody C Frear; Lela Kardava; Wei Wang; Clarisa M Buckner; Yimeng Wang; Olivia R Fankuchen; Kathleen R Gittens; Tae-Wook Chun; Yuxing Li; Anthony S Fauci; Susan Moir
Journal:  JCI Insight       Date:  2016-03-17

3.  The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens.

Authors:  Scott G Kitchen; Jason K Whitmire; Nicole R Jones; Zoran Galic; Christina M R Kitchen; Rafi Ahmed; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-24       Impact factor: 11.205

4.  Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.

Authors:  K A Green; R J Noelle; B G Durell; W R Green
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Authors:  Mohammed A Sadat; Susan Moir; Tae-Wook Chun; Paolo Lusso; Gerardo Kaplan; Lynne Wolfe; Matthew J Memoli; Miao He; Hugo Vega; Leo J Y Kim; Yan Huang; Nadia Hussein; Elma Nievas; Raquel Mitchell; Mary Garofalo; Aaron Louie; Derek C Ireland; Claire Grunes; Raffaello Cimbro; Vyomesh Patel; Genevieve Holzapfel; Daniel Salahuddin; Tyler Bristol; David Adams; Beatriz E Marciano; Madhuri Hegde; Yuxing Li; Katherine R Calvo; Jennifer Stoddard; J Shawn Justement; Jerome Jacques; Debra A Long Priel; Danielle Murray; Peter Sun; Douglas B Kuhns; Cornelius F Boerkoel; John A Chiorini; Giovanni Di Pasquale; Daniela Verthelyi; Sergio D Rosenzweig
Journal:  N Engl J Med       Date:  2014-04-09       Impact factor: 91.245

6.  Human tissue mast cells are an inducible reservoir of persistent HIV infection.

Authors:  J Bruce Sundstrom; Jane E Ellis; Gregory A Hair; Arnold S Kirshenbaum; Dean D Metcalfe; Hong Yi; Adriana C Cardona; Michael K Lindsay; Aftab A Ansari
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

Review 7.  Stem cell-based approaches to treating HIV infection.

Authors:  Scott G Kitchen; Jerome A Zack
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

8.  Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.

Authors:  Hiroki Goto; Yuki Kojima; Hirokazu Nagai; Seiji Okada
Journal:  Int J Hematol       Date:  2013-04-21       Impact factor: 2.490

9.  Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.

Authors:  Ann Marie Nelson; Aaron Auerbach; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2009-09-22       Impact factor: 6.580

10.  CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues.

Authors:  Nicolas Huot; Philippe Rascle; Cyril Planchais; Vanessa Contreras; Caroline Passaes; Roger Le Grand; Anne-Sophie Beignon; Etienne Kornobis; Rachel Legendre; Hugo Varet; Asier Saez-Cirion; Hugo Mouquet; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.